46-Year-Old Sharjah Resident with Uncontrolled Glaucoma Successfully Treated with Microshunt Surgery at Aster Hospital Al Qusais
The patient, a financial professional residing in Sharjah, had been battling diabetes for four years and was receiving treatment for retinal vein occlusion elsewhere. She was referred to Aster Hospital Al Qusais after experiencing complications, including glaucoma, bleeding, and retinal detachment. She had been treated for blocked blood vessels (retinal vein occlusion) and underwent successful retinal detachment surgery performed by Dr. Boopathy Murugavel, Specialist Ophthalmology at Aster Hospital Al Qusais. She was also prescribed eye drops for glaucoma as part of her ongoing treatment. Despite being on maximum eye drops, her eye pressures remained critically high at 50 mmHG, causing severe pain and a significant risk of further vision loss.
Recognizing the complexity of her condition, Dr. Boopathy Murugavel recommended glaucoma microshunt surgery to address the issue. Microshunt surgery is a minimally invasive procedure designed to lower eye pressure in glaucoma patients. It involves the implantation of a small device in the eye to help fluid drain more effectively, reducing pressure and preventing further damage to the optic nerve. The microshunt surgery, a minimally invasive treatment option, successfully reduced the patient's eye pressure to 12mmHG – a normal and sustainable level. This surgery marks a significant milestone in Aster Hospital Al Qusais' expanding ophthalmology services.
Commenting on the procedure, Dr. Boopathy Murugavel, Specialist Ophthalmology at Aster Hospital Al Qusais, said, 'Neovascular glaucoma is one of the most challenging forms of glaucoma to treat, as it often results from conditions like diabetic retinopathy or blocked blood vessels in the eye (retinal vein occlusion). Traditional surgical options, such as trabeculectomy, carry a higher risk of bleeding and failure due to scarring. The microshunt procedure provides a safer and more effective alternative, offering better outcomes with minimal downtime and faster recovery. We are proud to have achieved such a positive result for our patient and look forward to providing advanced solutions to more patients in need.'
The patient expressed her heartfelt gratitude to Dr. Boopathy and the medical team at Aster Hospital Al Qusais, stating: 'I am truly thankful for the exceptional care I received. Dr. Boopathy and the team were supportive throughout the process, and I am relieved that my eye pressure is now under control. This surgery has brought me freedom from chronic pain, and I am forever grateful to Aster Hospital Al Qusais for restoring my quality of life.'
Glaucoma, often referred to as the 'silent thief of sight,' causes progressive vision loss due to increased eye pressure. Glaucoma is a group of eye diseases that can cause vision loss and blindness by damaging a nerve in the back of your eye called the optic nerve. The symptoms can start so slowly that you may not notice them, which is why regular eye exams are essential. Neovascular glaucoma, a more severe form, arises from poor blood circulation in the eye due to conditions like diabetic retinopathy and blocked blood vessels. The microshunt device offers a cutting-edge solution with reduced risk of complications and higher success rates, making it a game-changer in treating advanced glaucoma cases.
Notably, while glaucoma is more common in older adults, with those over 60 being six times more likely to develop the condition2, this case is exceptional, as the patient is only 46 years old. This emphasizes the importance of early detection and treatment of glaucoma, regardless of age.
This surgery highlights Aster Hospital Al Qusais' commitment to providing innovative, patient-centric care and reinforces its position as a leading healthcare provider in the UAE.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mid East Info
4 days ago
- Mid East Info
On World Organ Donation Day KFSHRC Announces 10 Kidney Exchange Transplants Completed in 48 Hours - Middle East Business News and Information
Riyadh: King Faisal Specialist Hospital and Research Centre (KFSHRC) successfully performed 10 kidney exchange transplants over two consecutive days, setting a global record for the highest number of such procedures conducted within a two-day span at a single center, coinciding with World Organ Donation Day on August 13. This milestone reinforces KFSHRC's position as a global leader in organ transplantation. This accomplishment reflects the hospital's high clinical readiness, the seamless coordination of its multidisciplinary medical teams, and its advanced systems for managing donor-recipient matching, alongside its extensive experience in executing complex transplant procedures. All of these factors enable KFSHRC to carry out this type of exchange transplantation with precision and within an exceptionally short timeframe. Paired kidney transplantation is an innovative approach that matches donor–patient pairs for mutual exchange. In this system, each donor gives a kidney to a patient with whom they have no direct relation, while their own relative receives a kidney from another donor. The process significantly improves compatibility rates and offers new hope to patients who face challenges in finding a suitable match within their families. Last year, KFSHRC celebrated a major milestone by completing more than 500 paired kidney transplants since the program was launched in 2011. Since launching its organ transplantation program in 1981, the hospital has successfully performed over 5,000 kidney transplants, placing it among an elite group of global transplant centers. In 2024, the hospital conducted 80 pediatric kidney transplants, the highest annual volume reported worldwide. This makes KFSHRC's pediatric kidney transplant program the largest of its kind compared to leading centers in the United States and Europe. This remarkable achievement underscores KFSHRC's commitment to its vision of being the provider of choice for specialized healthcare. By leveraging its skilled workforce, advanced technologies, and the integration of research and clinical programs, the hospital aims to deliver world-class treatment experiences both locally and globally, while enhancing the Kingdom's position as a leader in organ transplantation. KFSHRC has been ranked first in the Middle East and North Africa and 15th globally in the list of the world's top 250 Academic Medical Centers for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. Additionally, in the same year, it was ranked among the world's best 250 hospitals and included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine.
Mid East Info
04-08-2025
- Mid East Info
27-Year-Old Dubai Resident Successfully Treated for Rare Vein Condition at Aster Hospital Mankhool - Middle East Business News and Information
In a landmark medical achievement, Aster Hospital, Mankhool, ranked No. 4 on Newsweek's World's Best Hospitals in the UAE list for 2025, successfully treated a young Dubai resident diagnosed with Superior Vena Cava Syndrome (SVCS), a rare and potentially life-threatening vein condition that blocks blood flow from the upper body back to the heart. Muhammad Bilal, a 27-year-old Pakistani national, had been suffering from symptoms of SVCS since 2020. His condition began with swelling on the right side of his face and neck, which gradually spread to involve his eye and the entire face, along with the appearance of a swollen vein over his abdominal area. In addition, he experienced shortness of breath, severe headaches, and visibly enlarged veins across his neck, chest, and abdomen. Initially painless, the swelling eventually became painful and distressing. Despite multiple consultations at various hospitals in the UAE and his home country, his condition remained undiagnosed and untreated until he visited Aster Cedar Hospital and was referred to Dr. Roshan Rodney S, Specialist Vascular and Endovascular Surgeon at Aster Hospital Mankhool. Upon clinical assessment and imaging scans, doctors confirmed a complete blockage in the superior vena cava—a major vein that carries blood from the upper body back to the heart. As a result, the body had started forming alternate blood flow channels to bypass the obstruction. To treat the blockage, Dr. Roshan and his team opted for a minimally invasive vein procedure, which is now the preferred treatment for SVCS due to its lower risk profile and rapid symptom relief. Using advanced imaging tools, they performed balloon angioplasty and placed a self-expanding stent to open the blocked vein and restore normal blood flow to the heart. Speaking on the severity of the patient's condition, the complexity of the procedure, and the positive outcome achieved through a coordinated team effort, Dr. Roshan Rodney S, Specialist Vascular and Endovascular Surgeon at Aster Hospital Mankhool, said, 'The vein was completely blocked, and the body had formed alternate routes to keep blood flowing. With the support of our anesthesia, cardiology, and ICU teams, we were able to restore blood flow seamlessly. The patient began to show significant symptom relief within hours of the procedure.' The results were immediate and remarkable. By the following day, the swelling in Muhammad Bilal's face had significantly reduced, and the prominent veins on his neck and abdomen had disappeared. He is now recovering well, with follow-up scans confirming the stent is working properly and his condition continues to improve. Muhammad Bilal expressed his gratitude, saying, 'I had been suffering for years, trying different hospitals and doctors, but no one could identify the problem. At Aster Hospital, I finally found answers. Dr. Roshan immediately diagnosed my condition and provided the treatment I had been waiting for. The swelling is gone, the pain has stopped, and I feel like I can live normally again. The care I received from the doctors, nurses, and staff made me feel like I was with family. I'm so thankful to be able to return to my regular life.' This case shines a light on the growing use of endovascular stenting in treating rare vein conditions and highlights the value of early diagnosis, modern imaging, and teamwork in managing complex health issues. SVCS is most commonly caused by cancers such as lung cancer or lymphoma, which can press on or grow into the vein, this happens in about 70% of cases[1]. In around 30% of cases, it's linked to long-term use of medical devices like central venous catheters or pacemakers, which can damage the vein walls over time.[2] A small number of cases (about 3–5%) are related to genetic clotting disorders, where repeated blood clots cause scarring and narrowing of the vein. [3] In extremely rare cases, such as Muhammad Bilal's, the cause remains unknown and is called idiopathic SVCS. For patients and families grappling with unexplained vein-related conditions, this successful case offers hope, showing how timely diagnosis and the right treatment can truly change lives This milestone reflects Aster Hospital Mankhool's dedication to pioneering care and improving patient outcomes through timely diagnosis and minimally invasive interventions.
Mid East Info
23-07-2025
- Mid East Info
SGH achieves remarkable milestone: Five hospitals granted 5-star rating by Newsweek's Global Hospital Rating
Saudi German Health SGH, a leading healthcare group in the Middle East and North Africa (MENA) region, has reinforced its industry leadership with five of its hospitals in Saudi Arabia earning five-star ratings in Newsweek's Global Hospital Rating. The hospitals in Riyadh, Makkah, Madinah, Aseer, and Jeddah all received this rating, establishing SGH as the healthcare group with the most five-star-rated hospitals in the region. This latest milestone reinforces SGH's unwavering commitment to providing top-patient-centred healthcare, while upholding high clinical standards and embracing innovative healthcare solutions. It also reflects SGH's ongoing efforts to align with Saudi Arabia's ambitious Vision 2030 goals, which aim to improve quality of life and elevate the Kingdom's healthcare sector to global standards. Makarem Sobhi Batterjee, Vice Chairman of Saudi German Health, said: 'We are proud to be recognised once again as the healthcare group with the highest number of five-star-rated hospitals in the region. This achievement is a testament to our dedication to clinical excellence, innovation, and exceptional service. It is not the first time we lead the region with such accomplishments — earlier this year, we were also honoured with having the highest number of top-ranked hospitals in the region in Newsweek's World's Best Hospitals 2025 list. These achievements reflect our strong leadership, our proud Saudi identity, and our alignment with Vision 2030's healthcare transformation goals.' These recognitions by Newsweek emphasise SGH's role as a pioneer of healthcare excellence in the Kingdom and the wider region. By consistently meeting the highest international standards and achieving outstanding results, Saudi German Health continues to influence the future of healthcare across Saudi Arabia and beyond.
